NCT04366050: A trial that was reported late by University of California, San Diego
This trial has reported, although it was 477 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04366050 |
|---|---|
| Title | A Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy of Ramipril to Prevent ICU Admission, Need for Mechanical Ventilation or Death in Persons With COVID-19 |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 11, 2020 |
| Completion date | May 12, 2021 |
| Required reporting date | May 12, 2022, midnight |
| Actual reporting date | Sept. 1, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 477 |